Coronavirus: The Latest The Telegraph

It employs nearly one in ten UK workers, but it’s the industry set to suffer the most when England's new tier system comes into force. CEO of UKHospitality, Kate Nicholls tells Theodora Louloudis why limited evidence of infection in pubs and restaurants means the sector has been wrongly singled out, with ‘devastating’ consequences.
Read more on Christmas rules: https://bit.ly/361oNwP |
Read more on travel quarantine changes: https://bit.ly/371PVLG |
'Dosing error in trials led to Oxford vaccine's 90 per cent efficacy by accident': https://bit.ly/39bzCOU |
For 30 days' free access to The Telegraph: https://www.telegraph.co.uk/audio |
Email: coronaviruspodcast@telegraph.co.uk |
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hosted on Acast. See acast.com/privacy for more information.

Over a year since the first recorded case of Covid-19 in humans, only one antiviral drug is approved for its treatment. The Telegraph’s Global Health Security team speak to Dr Michael Elliot, Vice President of Medical Affairs at Gilead Sciences, the company that manufactures Remdesivir. They discuss how useful it is, whether big pharma is solely driven by profit and the prognosis for severe coronavirus sufferers in the second wave.
Read more on the Oxford vaccine: https://bit.ly/2UVfPet |
Read more on Brexit talks: https://bit.ly/36V8f8Y |
Read more on the new quarantine-free list: https://bit.ly/3lMs88H |
For 30 days' free access to The Telegraph: https://www.telegraph.co.uk/audio |
Email: coronaviruspodcast@telegraph.co.uk |
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hosted on Acast. See acast.com/privacy for more information.

After the US recorded its highest daily rise in new cases and hospitalisations, Deputy Editor of The Telegraph’s Global Health Security Team, Anne Gulland joins Theodora Louloudis to discuss the five mammoth challenges the President Elect will be seeking to overcome in his fight against Covid-19. Top of the list? Tackling misinformation.
Track cases in your area: https://bit.ly/2Yohewr |
Read more about the MS drug trial: https://bit.ly/3kB3nuM |
For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio |
Email: coronaviruspodcast@telegraph.co.uk |
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hosted on Acast. See acast.com/privacy for more information.

After the Pfizer vaccine breakthrough, immunologist Dr Al Edwards tells Theodora Louloudis why the hard work isn't over even once a vaccine is approved, why talk of effective immunisation before Christmas is premature and how this particular vaccine could be particularly difficult to distribute.
Read more about the rise in deaths in England and Wales: https://bit.ly/2GLAwWw |
Read more about unemployment rates: https://bit.ly/3llycof |
Read more about Welsh exams: https://bit.ly/36oNeDo |
Read Sarah Newey 'We should be concerned about the 'mink virus', but not for the reasons you think': https://bit.ly/3lu966w |
For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio |
Email: coronaviruspodcast@telegraph.co.uk |
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hosted on Acast. See acast.com/privacy for more information.

As Liverpool becomes England’s first city to be offered mass coronavirus testing, The Telegraph’s Health Editor Laura Donnelly tells Theodora Louloudis why the trial could offer a glimpse into the UK’s future, and why its success hinges on public co-operation.
Read more the UK's R-rate: https://bit.ly/35YCHyB |
Read more about Paris' coronavirus infection rates: https://bit.ly/2HXCEe4 |
Read Ambrose Evans-Pritchard' 'Boris has my full support on lockdown 2.0 - even though I think he’s wrong': https://bit.ly/34T24Tl |
For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio |
Email: coronaviruspodcast@telegraph.co.uk |
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hosted on Acast. See acast.com/privacy for more information.

With just eight weeks to go until the big day, Yolanthe Fawehinmi joins Theodora Louloudis to discuss the likelihood of households being allowed to mix nationwide over the festive season.
Read more about England's coronavirus infection rates: https://bit.ly/31TdwMJ|
Read more about the leaked sage documents: https://bit.ly/34GV4ZE|
For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio |
Email: coronaviruspodcast@telegraph.co.uk |
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hosted on Acast. See acast.com/privacy for more information.